• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)

PRODUCT FILTERS

REGION

23
13
9
5
5

COUNTRY

5
5
4
4

CATEGORIES

  • 25
  • 22
  • 13
  • 3
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1

PRICE

28
44
53
69

PUBLISHED

1
3
11
69

PRODUCT TYPE

46
23

Search "Evidence-Based Oncology. Evidence-Based Medicine" returned 69 results.

PRODUCT TITLE

Evidence-Based Pediatric Oncology. 3rd Edition. Evidence-Based Medicine

This book is updated with evidence from the latest published reviews and is more clinically focused, with an emphasis on application of the trial findings. With increased coverage of trials in the area...

April 2013
Personalized Medicine - Scientific and Commercial Aspects Personalized Medicine - Scientific and Commercial Aspects - Product Thumbnail Image

Personalized Medicine - Scientific and Commercial Aspects

The aim of personalized medicine or individualized treatment is to match the right drug to the right patient and, in some cases, even to design the appropriate treatment for a patient according to his/her...

August 2014
FROM
Personalized Medicine 2010 Personalized Medicine 2010 - Product Thumbnail Image

Personalized Medicine 2010

Assessing the Opportunities and Challenges in Commercializing Companion Diagnostics and Targeted Therapies The era of Personalized Medicine is set to revolutionize the healthcare industry As our knowledge...

May 2010
FROM
Risk Sharing and Other Forms of Managed Entry Agreements for Medicines, Worldwide Risk Sharing and Other Forms of Managed Entry Agreements for Medicines, Worldwide - Product Thumbnail Image

Risk Sharing and Other Forms of Managed Entry Agreements for Medicines, Worldwide

Managed entry agreements apply to an increasing number of new, innovative drugs in a growing number of markets They are designed to share the risk between the manufacturer and the payer, consequent...

February 2013

Genetics Bundle

The Genetics Bundle includes the following reports at a 15% discount off the individual reports being purchased separately: - Bioinformatics Markets - DNA Sequencing and PCR Markets - Gene Expression...

June 2012
FROM

Evidence-based Orthopedics. Evidence-Based Medicine

Surgical orthopedic procedures such as hip replacements, arthroscopy or knee replacements are surrounded by pre- and post-operative complications, and there are varying different methods for the procedures...

December 2011

Telemedicine and M-Health Convergence: Market Shares, Strategies, and Forecasts, Worldwide, 2013 to 2019

Clinical telemedicine services converge with m-health systems of engagement to lower cost of care and improve quality of care Tele-medicine and M-Health Market Convergence driving forces relate to an...

September 2013
FROM
Cord Blood Stem Cells – A Global Market Overview Cord Blood Stem Cells – A Global Market Overview - Product Thumbnail Image

Cord Blood Stem Cells – A Global Market Overview

Industry Experts, a multi industry focused market research firm, has released an updated version of their 2009 published biotechnology market research report ‘Cord Blood Stem Cells – A Global Market...

October 2011
FROM

Radiation Oncology in Palliative Cancer Care

“This textbook, Radiation Oncology in Palliative Cancer Care, represents the full evolution of radiation therapy, and of oncology in general. ( … ) [It] is an acknowledgment that palliative radiotherapy...

May 2013

Gynecologic Oncology. Evidence-Based Perioperative and Supportive Care. 2nd Edition

- New edition fully includes Grades and Levels of evidence, providing a better idea of what the sum total of existing evidence suggests regarding key topics - Grades and levels of evidence consistently...

August 2011

Emerging Drug Delivery Technologies, Profiles of Start-ups and Early-Stage Companies

MCD Group continuously researches and monitors emerging drug delivery technologies and has compiled this report to profile some of the innovative developments at younger, emerging companies The report...

May 2013
FROM

Gene Therapy Market to 2018 - Product Development Slowed by Clinical Failures, Close Regulatory Surveillance and High Compliance Standards

Gene Therapy Market to 2018 - Product Development Slowed by Clinical Failures, Close Regulatory Surveillance and High Compliance Standards Summary GBI Research’s new report, “Gene Therapy Market to...

June 2012
FROM
Strategic Analysis of Optical Imaging Technologies in U.S. Clinical Diagnostics and Drug Discovery Markets Strategic Analysis of Optical Imaging Technologies in U.S. Clinical Diagnostics and Drug Discovery Markets - Product Thumbnail Image

Strategic Analysis of Optical Imaging Technologies in U.S. Clinical Diagnostics and Drug Discovery Markets

This research service analyzes optical technologies within the United States clinical imaging and drug discovery markets The market is further divided into seven distinct sub-segments Each segment covers...

March 2009
FROM

Notes on Feline Internal Medicine. 2nd Edition

Helping you get started with a problem solving approach to a sick cat. Notes on Feline Internal Medicine 2nd edition is part of a popular series specifically designed, through an accessible note-based...

September 2013

Companion Biomarkers in Drug Development

Companion biomarkers are diagnostic tests that are specifically linked to a therapeutic drug either during its development or in the clinic This linkage can be an important component of the drug development...

August 2013
FROM

Biologics and Biosimilars World Markets

Biologics are complex molecules manufactured through cell culture recombinant DNA technology Biologics additionally comprise recombinant insulin, growth hormone and monoclonal antibodies for treating...

August 2013
FROM

Molecular Diagnostics in Cancer Testing

Molecular diagnostics is a rapidly-advancing area of research and medicine, with new technologies and applications being continually added The technologies that come under the umbrella of molecular...

November 2013
FROM

Chronic Pain: An Atlas of Investigation and Management

Chronic pain affects nearly one in every four adults worldwide, with pain one of the most common symptoms resulting in medical consultation The increasing focus on chronic pain presents difficulties...

September 2009
FROM
Multiple Sclerosis: KOL Insight Multiple Sclerosis: KOL Insight - Product Thumbnail Image

Multiple Sclerosis: KOL Insight

An incisive report and dynamic analyst briefing service delivering insight from the most influential Multiple Sclerosis (MS) Key Opinion Leaders to map the current treatment landscape and analyse future...

December 2013
FROM

Molecular Diagnostics Reports Bundle

The Molecular Diagnostics Reports Bundle includes the following publications at a 15% discount off the individual reports being purchased separately: - Molecular Diagnostics in Cancer Testing - Molecular...

November 2013
FROM
Loading Indicator